Showing results (31-40 of 4,789) with videos related to

Sort By:
Pageof 479
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2010
A method for evaluating treatment switching criteria in multiple sclerosisBrian C Healy, Bonnie I Glanz, James Stankiewicz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2010
A case of cerebral aquaporinopathyA Tanaka, T Yoshida, T Yamada, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2010
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosisMassimiliano Calabrese, Francesca Rinaldi, Paola Grossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 31, 2010
Modifications to the McDonald MRI dissemination in space criteria for use in Asians with classic multiple sclerosis: the Taiwanese experienceShao-Yuan Chen, Chung-Ping Lo, Wen-Lin Hsu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2010
Psychometric properties of the Fatigue Severity Scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohortA Lerdal, S Johansson, A Kottorp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
MS prevalence in New Zealand, an ethnically and latitudinally diverse countryBruce V Taylor, John F Pearson, Glynnis Clarke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosisA Solari, K Mattarozzi, L Vignatelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2010
Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkersChiara Ferrandi, Fabien Richard, Patrizia Tavano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2010
Causes of death among patients with multiple sclerosisMarja-Liisa Sumelahti, Matti Hakama, Irina Elovaara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2010
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologistsChristoph Heesen, Ingo Kleiter, Franziska Nguyen, et al.
Pageof 479